Tango Therapeutics Inc (TNGX)
7.55
-0.24
(-3.08%)
USD |
NASDAQ |
May 17, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Free Cash Flow: -122.03M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -122.03M |
| December 31, 2023 | -119.51M |
| September 30, 2023 | -121.12M |
| June 30, 2023 | -112.86M |
| March 31, 2023 | -121.07M |
| Date | Value |
|---|---|
| December 31, 2022 | -116.77M |
| September 30, 2022 | -105.06M |
| June 30, 2022 | -104.44M |
| March 31, 2022 | -78.81M |
| December 31, 2021 | -61.36M |
Free Cash Flow Range, Past 5 Years
-122.03M
Minimum
Mar 2024
-61.36M
Maximum
Dec 2021
-106.30M
Average
-114.82M
Median
Free Cash Flow Benchmarks
| Aquestive Therapeutics Inc | -26.60M |
| 2seventy bio Inc | -168.04M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.86M |
| Cash from Investing (Quarterly) | -11.20M |
| Cash from Financing (Quarterly) | 42.98M |
| Free Cash Flow Per Share (Quarterly) | -0.3518 |
| Free Cash Flow to Equity (Quarterly) | -38.05M |
| Free Cash Flow to Firm (Quarterly) | -38.05M |
| Free Cash Flow Yield | -16.31% |